Quick Heal Technolog News

Closure of Trading Window

Select stocks gain momentum even in volatile markets.

The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sneha Kailash Katkar

The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anupama Kailash Katkar

Intimation of Product Launch and issue of India Cyber Threat Report 2025

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anupama Kailash Katkar

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sneha Kailash Katkar

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kailash Sahebrao Katkar

Allotment of 27,125 equity shares under ESOP 2014 Scheme and ESOP Scheme 2021.

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anupama Kailash Katkar

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sneha Kailash Katkar

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anupama Kailash Katkar

Transcript of Earning Call held on 18 October 2024

Allotment of 50150 equity shares under ESOP 2014 scheme and ESOP 2021 scheme

Half Yearly Results for FY 2024-25

Half Yearly Results FY 2024-25

Earnings Call for Quarter 2 Financial year 2024-25

Quick Heal Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2024 ,inter alia, to consider and approve the quarter and half year results for the year ended 30 September 2024

Compliance Certificate under 74 (5)

ALLOTMENT OF 44935 EQUITY SHARES UNDER ESOP 2014 AND ESOP 2021 SCHEME

New Product Launch - AntiFraud.AI

Closure of Trading Window

Re-Appointment of MSKA & Associates as Statutory Auditors at the Annual General Meeting.

Appointment of Mr. Kamal Kumar Agarwal at the Annual General Meeting.

Appointment of Mr. Amitabha Mukhopadhyay at the Annual General Meeting.

Scrutinizer''s Report on remove E-voting prior and during AGM and voting results as prescribed in format pursuant to regulation 44 (3) of LODR.

Outcome of Annual General Meeting held on 6th September 2024 at 4 p.m.

Allotment of under 28725 under ESOP Scheme 2014 and ESOP Scheme 2021

Newspaper Publication of 29th Annual General Meeting

The Register of Members and share transfer books of the Company will be closed from August 31, 2024 to September 6, 2024 both days inclusive

The Register of members and share transfer books of the Company will be closed from August 31, 2024 to September 6, 2024 both day inclusive

Notice of Annual General Meeting to be held on September 6, 2024

Business Responsibility and Sustainability Report for the Financial Year 2023-24

Annual Report for the Financial Year 2023-24

Public Notice of 28th Annual General Meeting to be held on September 6, 2024 at 4:00 PM.

Allotment of 199535 Equity Shares under ESOP Scheme 2014 and ESOP Scheme 2021

Intimation of Investor Meet

Transcript of earning call held on July 29, 2024

Outcome of Earning Call for Q1 FY25

NEWSPAPER PUBLICATION OF FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2024